ARCHIVES

NCI Phase II Trial Tests Vaccine Plus Hormone Therapy For Recurrent Prostate Cancer

This article is from The Cancer Letter archive.

Vol. 28 No. 8 | August 26, 2005

Download PDF Visit The Full Archive

Related Articles

Proflavine Bioassay Ineffective, NCI Says

July 15, 1977

OPR Reinstates Duke Medical Center’s License To Conduct Human Studies

May 28, 1999

Research Base Would Be Increased In Guideline Change

November 9, 1990

USPSTF and ACS Recommend Less Frequent Cervical Cancer Screenings and Pap Smears

March 30, 2012

NIAMDD Scientists Find Virus Gene Causes, Continues Cancer

May 9, 1975

DCT Board Approves New Imaging Study In Split Vote, Small Grant Program

October 27, 1989